Developmental consequences of hypothalamic-pituitary-adrenocortical system disruption: Impact on thymus gland maturation and the susceptibility to develop neuroimmune diseases

Developmental Brain Dysfunction

Volumn 10, Issue 6, 1997, Pages 503-527

  Marchetti, Bianca ^a,f   Gallo, Francesco ^g   Tirolo, Cataldo ^a   Saucedon, Rosa ^b   Testa, Nuccio ^a   Farinella, Zelinda ^g   Barden, Nicholas ^c   Brouwer, Jantien ^d   Huitinga, Inge ^e   Zapata, Augustin ^c   Dijkstra, Christine ^d   Morale, Maria C ^a  

^a OASI RESEARCH INSTITUTE IRCCS   (Italy)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSITÉ LAVAL   (Canada)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^f UNIVERSITY OF CATANIA   (Italy)

^g NONE

Author keywords

Adrenalectomy; Antisense RNA; Autoimmunity; Cytokines; Glucocorticoid receptor messenger ribonucleic acid concentration; Immune response; Multiple sclerosis; Sex steroids; Stress; T cell ontogeny; T cell trafficking; Transgenic animals

Indexed keywords

CORTICOTROPIN; CYTOKINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; SEX HORMONE;

ADRENAL FUNCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FETUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREACTIVITY; MALE; MOUSE; NEWBORN; NONHUMAN; RAT; REVIEW; SEX DIFFERENCE; STRESS; T LYMPHOCYTE; THYMOCYTE; THYMUS; TRANSGENIC MOUSE;

EID: 0031545606     PISSN: 10195815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Burnstein KL, Cidlowski JA: Regulation of gene expression by glucocorticoids. Ann Rev Physiol 1989;51:683-699.
2. O'Malley B: The steroid receptor superfamily: More excitement predicted for the future. Mol Endocrinol 1990;4:363-369.
3. Beato M: Gene regulation by steroid hormones. Cell 1989;56:335-344.
4. Carson-Jurica MA, Schrader WT, O'Malley BW: Steroid receptor family: Structure and function. Endocr Rev 1990;11:201-220.
5. McEwen BS, Weiss JM, Schwartz LS: Selective retention of corticosterone by limbic structures in rat brain. Nature 1968;220:911-912.
6. McEwen BS, Davis PG, Parsons B, Pfaff DW: The brain as a target for steroid hormone action. Annu Rev Neurosci 1979;2:68-112.
7. Reul JM, de Kloet ER: Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology 1985;117: 2505-2511.
8. Munk A, Guyre PM, Holbrook NJ: Physiological fluctuations of glucocorticoids in stress and their relation to pharmacological action. Endocr Rev 1984;5:25-44.
9. Antoni FA: Hypothalamic control of adenocorticotropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 1986;7:351-378.
10. Chrousos GP, Gold PW: The concept of stress and stress sytem disorders: Overview of physical and behavioral homeostasis. JAMA 1992; 267:1244-1252.
11. Chrousos GP: Ultradian, circadian, and stress-related hypothalamic-pituitary-adrenal axis activity. A dynamic digital-to-analog modulation (editorial). Endocrinology 1998;139:437-440.
12. Windle RJ, Wood SA, Shanks N, Lightman SL, Ingram CD: Ultradian rhythm of basal corticosterone release in female rat: Dynamic interaction with the response to acute stress. Endocrinology 1998;139:443-450.
13. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-1362.
14. Sternberg EM: The role of the hypothalamic-pituitary-adrenal axis in an experimental model of arthritis. Prog Neuroendocrinoimmunol 1989;2: 103-108.
15. Wick G, Hu Y, Schwarz S, Kroemer G: Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endcr Rev 1993;14:539-563.
16. Weidenfield J, Yirmiya R: Effects of bacterial endotoxin on the glucocorticoid feedback regulation of adrenocortical response to stress. Neuroimmunomodulation 1996;3:352-357.
17. Gillis S, Crabtree GR, Smith KA: Glucocorticoid-induced inhibition of T cell growth factor production. II. The effect of the in vitro generation of cytolytic T cells. J Immunol 1979;123:1624-1629.
18. Lee SW, Tsou A-P, Chan H, Thomas J, Petrie K, Egui M, Allison AC: Glucocorticoids selectively inhibit the transcription of the interleukin beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci USA 1982;85: 1204-1208.
19. Culpepper JA, Lee F: Regulation of IL-3 expression by glucocorticoids in cloned murine T lymphocytes. J Immunol 1985;135:3191-3195.
20. Spangelo B, McLeod RM: Regulation of the acute phase response and neuroendocrine function by IL-6. Prog Neuroendocrinoimmunol 1990;3:167-175.
21. Zanker B, Wal G, Wieder KJ, Strom TB: Evidence that glucocorticosteroids block the expression of the human interleukin-6 gene by accessory cells. Transplantation 1990;49:183-187.
22. Marchetti B: Cross-talk signals in the CNS: Role of neurotrophic and hormonal factors, adhesion molecules and intercellular signaling agents in luteinizing hormone-releasing hormone (LHRH)-astroglial interactive network. Front Biosci 1997; 2:88-125.
23. Giulian D: Microglia and neuronal dysfunction; in Kattenmann H, Ransom BR (eds): Neuroglia. Oxford, Oxford University Press, 1995, pp 671-684.
24. 2-adrenergic receptor in the rat thymus gland and presence of a sexual dimorphism during ontogenic development. Prog Neuroendocrinoimmunol 1990;3:103-115.
25. Morale MC, Gallo F, Batticane N, Marchetti B: The immune response evokes up-and down-modulation of a beta-adrenergic receptor messenger ribonucleic acid concentration in the male rat thymus. Mol Endocrinol 1992;6:1513-1524.
26. Marchetti B, Peiffer A, Morale MC, Batticane N, Gallo F, Barden N: Transgenic animals with impaired type II glucocorticoid receptor expression: A model to study aging of the neuroendocrine immune system. Ann NY Acad Sci 1994;719: 308-327.
27. Iseki R, Mukai M, Iwata M: Regulation of T lymphocyte apoptosis. Signals for the antagonism between activation and glucocorticoid induced death. J Immunol 1991;147:4286-4292.
28. Troiano L, Monti D, Cossarizza A, Lovato E, Tropea F, Barbieri D, Morale MC, Gallo F, Marchetti B, Franceschi C: Involvement of CD45 in dexamethasone and heat shok induced apoptosis of rat thymocytes. Biochem Biophys Res Commun 1995;214:941-948.
29. McEwen BS: Protective and damaging effects of stress mediators. New Engl J Med 1998;238: 171-179.
30. Jacobson L, Sapolsky RM: The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenal axis. Endocr Rev 1991;12: 118-134.
31. Sapolsky R: Stress, the Aging Brain, and Mechanisms of Neuron Death. Cambridge, MIT Press, 1992.
32. McEwen B, Sapolsky RM: Stress and cognitive function. Curr Opin Neurobiol 1995;5:205-212.
33. Sapolsky RM: Stress, glucocorticoids, and damage to the nervous system: The current state of confusion. Stress 1996;1:1-19.
34. Holsboer F, Bardeleben U, Gerken A, Stalla GK, Muller OA: Blunted corticotropin releasing factor in depression. New Engl J Med 1984;311:1127.
35. Barden N: Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci 1995;18: 6-11.
36. Maes M, Smith R, Scharpe S: The monocyte T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 1995;20:111-116.
37. Yirmiya R: Endotoxin produces a depressive-like episode in rats. Brain Res 1996;711:163-174.
38. McGeer EG, McGeer PL: Neurodegeneration and the immune system; in Calne DB (ed): Neurodegenerative Diseases. Harcour Brace, Saunders, 1994, pp 277-299.
39. Kreutzberg GW: Microglia: A sensor for pathological events in the CNS. Trends Neurosci 1996; 19:312-317.
40. Zettl UK, Gold R, Toyka KV, Hartuns H-P: Intravenous glucocorticosteroid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat. J Neuropathol Exp Neurol 1995;54:540-547.
41. Dyck PJ, O'Brien PC, Oviatt KF: Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982;11:136-141.
42. McPhee IA, Antoni FA, Mason DW: Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenalocorticosteroids. J Exp Med 1989;169:431-445.
43. Beck RW, Cleary PA, Trobe JD: The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 1993;329:1767-1769.
44. Warren S: Emotional stress and development of multiple sclerosis: Case control evidence of a relationship. J Chronic Dis 1982;35:821-831.
45. Whitlock FA, Siskind MM: Depression as a major symptom of multiple sclerosis. J Neurol Neurosurg Psychiatry 1980;43:861-868.
46. Marchetti B, Gallo F, Farinella Z, Morale MC: Unique neuroendocrine-immune interactions during pregnancy; in Kendall M, Marsch J (eds): The Physiology of Immunity. London, CRC Press, 1996, pp 297-328.
47. Marchetti B, Morale MC, Gallo F, Batticane N, Farinella Z, Cioni M: Neuroendocrinoimmunology at the turn of the century: Towards a molecular understanding of basic mechanisms and clinical implications for reproductive physiology. Endocrine 1995;3:845-871.
48. Porter NM, Landfield PW: Stress hormones and brain aging: Adding injury to insult? Nat Neurosci 1998;1:3-4.
49. Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NPV, Thakur M, McEwen BS, Hauger RL, Meaney MJ: Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1998;1:69-72.
50. Pepin MC, Poithier F, Barden N: Impaired type II glucocorticoid receptor function in mice bearing antisense RNA transgene. Nature 1992;355: 725-728.
51. Pepin MC, Pothier F, Barden N: Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol Pharmacol 1993;42:991-995.
52. Holsboer F, Barden N: Antidepressant and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996;17:187-205.
53. Stec I, Barden N, Reul JMH, Holsboer F: Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor. J Psychiatr Res 1994;28:1-5.
54. Karanth S, Linthorst ACE, Stalla GK, Barden N, Holsboer F, Reul JMHM: Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function. Endocrinology 1997;138:3476-3485.
55. Morale MC, Batticane N, Gallo F, Barden N, Marchetti B: Disruption of hypothalamic-pituitary-adrenocortical system in transgenic mice expressing type glucocorticoid receptor antisense ribonucleic acid permanently impairs T cell functions: Effects on T cell trafficking and T cell responsiveness during postnatal development. Endocrinology 1995;136:3949-3960.
56. Boyd RL, Tucek CL, Godfrey DI, Izon DJ, Wilson TJ, Davison NJ, Bean AGD, Ladyman HM, Ritter MA, Hugo P: Inside the Thymus: The thymic microenvironment. Immunol Today 1993;14: 445-459.
57. Ritter MA, Boyd RL: Development in the thymus: It takes two to tango. Immunol Today 1993;14: 460-469.
58. Palmer DB, Hayday A, Owen MJ: Is TCR β expression an essential event in early thymocyte development? Immunology Today 1993;14:460-462.
59. Carding SR, Hayday AC, Bottomly K: Cytokines in T cell development. Immunol Today 1991;12: 239-245.
60. Saplosky RM, Meaney MJ: Maturation of the adrenocortical stress response: Neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res Rev 1986;11:68-76.
61. Widmaier EP: Glucose homeostasis and hypothalamic-pituitary-adrenocortical axis during development in rats. Am J Physiol 1990;259:E601-E613.
62. Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW: Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA 1989;86:4771-4775.
63. Aksentijevich S, Whitfield HJ Jr, Young WS 2nd, Wilder RL, Chrousos GP, Gold PW, Sternberg EM: Arthritis-susceptible Lewis rats fail to emerge from the stress hyporesponsive period. Brain Res Dev Brain Res 1992;68:115-118.
64. Catalani A: Neonatal exposure to glucocorticoids: Long-term endocrine and behavioral effects. Dev Brain Dysfunct 1997;10:393-404.
65. Bakker JM, van Rees EP: Prenatal stress and immunocompetence in later life. Dev Brain Dysfunct 1997;10:445-461.
66. Buckingham JC, Flower RJ, Kikkert R, Loxley HD: Secretion of corticotrophin-releasing hormone and arginine vasopressin by the neonatal rat hypothalamus in vitro: Age-dependent maturation of the responses to cytokines and modulation by glucocorticoids and lipocortin 1. Dev Brain Dysfunct 1997;10:482-502.
67. Reul JMH, Pearce PT, Funder JW, Krozowski ZS: Type I and Type II corticosteroid gene expression in the rat: Effect of adrenalectomy and dexamethasone administration. Mol Endocrinol 1989;3: 1674-1680.
68. De Kloet ER, Rosenfeld P, Van Eekelen JAM, Sutanto W, Levine S: Stress, glucocorticoids and development. Prog Brain Res 1988;73:101-120.
69. Meaney MJ, Sapolsky RM, McEwen BS: The development of the glucocorticoid receptor system in the rat limbic brain. I. Ontogeny and autoregulation. Brain Res 1985;350:159-167.
70. Miller AH, Spencer RL, Stein M, McEwen BS: Adrenal steroid receptor binding in spleen and thymus after stress or dexametasone. Am J Physiol 1990;193:E405-E412.
71. Miller AH, Spencer RL, Trestman RL, McEwen BS, Stein M: Adrenal steroid receptor activation in vivo and in vitro and immune function. Am J Physiol 1991;261:E126-E131.
72. Miller AH, Spencer RL, Husain A, Rhee R, McEwen BS, Stein M: Differential expression of type I adrenal steroid receptors in immune tissues is associated with tissue-specific regulation of type II receptor by aldosterone. Endocrinology 1993; 133:2133-2140.
73. Patchev VK, Hayashi S, Orikasa C, Almeida OFX: Implications of estrogen-dependent brain organization for gender differences in hypothalamo-pituitary-adrenal regulation. FASEB J 1995;9:419-423.
74. Peiffer A, Morale MC, Barden N, Marchetti B: Modulation of glucocorticoid receptor gene expression in the thymus by the sex steroid hormone milieu and correlation with sexual dimorphism of immune response. Endocr J 1994;2:181-192.
75. Peiffer A, Lapointe B, Barden N: Hormonal regulation of type II glucocorticoid receptor messenger ribonucleic acid in rat brain. Endocrinology 1991;129:2166-2174.
76. Peiffer A, Barden N: Glucocorticoid receptor gene expression in rat pituitary gland intermediate lobe following ovariectomy. Mol Cell Endocrinol 1988;55:115-120.
77. Patchev VK, Almeida OFX: Gonadal steroids exert facilitating 'buffering' effects on glucocorticoid-mediated transcriptional regulation of corticotropin-releasing hormone and corticosteroid receptor genes in rat brain. J Neurosci 1996;16: 7077-7084.
78. Marchetti B: Involvement of the thymus in reproduction. Prog Neuroendocrinoimmunol 1989;2: 67-69.
79. Grossman CJ: Are there underlying immune-neuroendocrine interactions responsible for immunological sexual dimorphism? Prog Neuroendocrinoimmunol 1990;3:75-82.
80. Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, Gold PW: Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis unction. J Clin Endocrinol Metab 1994;79:848-853.
81. Reder AT, Mackowiec RL, Lowy MT: Adrenal size is increased in multiple sclerosis. Arch Neurol 1994;51:151-154.
82. Grasser A, Möller A, Backmund H, Yassourdisis A, Holsboer F: Heterogeneity of the hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Exp Clin Endocrinol 1996;104:31-37.
83. Wei T, Lightman SL: The neuroendocrine axis in patients with multiple sclerosis. Brain 1997;120: 1067-1076.
84. Fassbender K, Schmidt R, Mössner H, Kisscka U, Kühnen J, Schwartz A, Hennerici M: Mood disorders and dysfunction of the hypothalamus-pituitary-adrenal axis in multiple sclerosis. Arch Neurol 1998;55:66-72.
85. Goulding NJ, Guyre PM: Glucocorticoids, lipocortins and the immune response. Curr Opin Immunol 1993;5:108-113.
86. Stemberg EM: Neural-immune interactions in health and disease. J Clin Invest 1997;100:2671-2677.
87. MacPhee IA, Antoni F, Mason DW: Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on relation of the immune system by endogenous adrenal corticosteroids. J Exp Med 1989;69:431-445.
88. Bolton C, Flower RJ: Effects of anti-glucocorticoid RU 38486 on steroid-mediated suppression of experimental allergic encephalomyelitis. Life Sci 1989;45:97-101.
89. Polman CH, Hartung H-P: Treatment ofmultiple sclerosis: Current and future. Curr Opin Neurol 1995;8:200-209.
90. Sternberg EM, Young WS 2nd, Bernardinin R, Calogero AW, Chrousos GP, Gold PW, Wilder RL: A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rat. Proc Natl Acad Sci USA 1989;86:4771-4775.
91. Mason DW, MacPhee I, Antoni F: The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis. Immunology 1990;70:1-5.
92. Lew W, Oppenheim JJ, Matsushima K: Analysis of suppression of IL-1alpha and IL-1beta production in peripheral blood mononuclear adherent cells by glucocorticoid hormone. J Immunol 1988;140: 1895-1901.
93. Beutler BN, Krochin IW, Milsark C, Ludeka C, Cerami A: Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 1986;232:977-979.
94. Flower RJ: The anti-inflammatory effects of corticosteroids; in Dale MM, Foreman C (eds): Textbook of Pharmacology. Oxford, Blackwell, 1989, pp 275-295.
95. Werb Z: Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions. J Exp Med 1978;147:1695-1701.
96. Palioganni F, Ahuja SS, Balow JP, Boumpas DT: Novel mechanism for inhibition of human T cells by glucocorticoids. J Immunol 1993;151: 4081-4087.
97. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G: A mechanism for anti-inflammatory effects of glucocorticoids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and the expression of endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1992;89:9991-9995.
98. Fauci AS: Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and B lymphocytes to the bone marrow. Immunology 1775;28:669-679.
99. Mason DW: Genetic variation in the stress response: Susceptibility to experimental allergic encephalomyeltis and implications for human inflammatoty disease. Immunol Today 1991;12: 57-63.
100. Mosmann TR, Coffman RL: TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-168.
101. Daynes RA, Areno B: Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol 1989;19:2319-2325.
102. + T cells in vitro. J Immunol 1996;156:2406-2412.
103. Stam WB, Van Oosterhout AJM, Nijkamp FP: Pharmacological modulation of Th1-and Th2-associated lymphokine production. Life Sci 1993; 53:1921-1923.
104. Erkut ZA, Hofman MA, Ravid R, Swaab DF: Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis. J Neuroimmunol 1995;62:27-33.
105. Klebl H, Weber G, Kalden JR, Nusslein HG: In vitro and in vivo effects of glucocorticoids on IgE and IgG subclasses. Clin Exp Allergy 1994;24: 1022-1029.
106. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS: Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1993;35: 1281-1288.
107. Bakker JM, Schmidt ED, Kroes H, Kavelaars A, Heynen CJ, Tilders FJH, Van Rees EP: Effects of neonatal dexamethasone treatment on hypothalamo-pituitary-adrenal axis and the immune system in the rat. J Neuroimmunol 1997;74:69-76.
108. Chun HT, Samlowski WE, Daynes RA: Modification of the murine immune system by glucocorticoids: Alterations in the tissue localization properties of circulating lymphocytes. Cell Immunol 1986;101:571-585.
109. Meaney MJ, Aitken DH, Sharma S, Viau V: Basal ACTH, corticosterone and corticosterone-binding globulin levels over the diurnal cycle, and age-related changes in hippocampal type I and type II corticosteroid receptor binding capacity in young and aged, handled and nonhandled rats. Neuroendocrinology 1992;55:204-213.